We will be participating in the near future in a clinical research trial using leronlimab, which is a unique monoclonal antibody. We are pre-screening patients for this long hauler clinical trial while we await the FDA approval of the protocol for use with the drug.
If you are accepted into the clinical trial by meeting all of the Inclusion/Exclusion criteria, there will be no cost to the patient for participation. Please book online or call us at 305-405-1590 for more information or to make an appointment.
*Appointment day and time not guarantee
*Bilingual patients are eligible for participation but study questionnaires are only available at this time in English
PARTICIPANT MUST BE LOCATED IN MIAMI, FLORIDA
Fill out the form and our team will contact you for an appointment
FILL OUT THE FORM AND OUR TEAM WILL CONTACT YOU FOR AN APPOINTMENT
2801 NE 213rd Street, Aventura, FL 33180